QbD Group
    White Paper

    The One-Vigilance strategic roadmap to corporate excellence

    This whitepaper introduces the concept of One Vigilance within the context of the current drug safety landscape. Download now.

    2024年11月4日

    关于本白皮书

    本资源涵盖的关键主题

    The objective of this whitepaper is to introduce the concept of One-Vigilance® within the context of the current drug safety landscape. It emphasizes the importance of directing the focus of pharmacovigilance experts towards a strategic orientation, while also considering the novel contributions of technology, digital innovation, patient focus, and real-world data.

    Additionally, the whitepaper aims to provide key insights to catalyze the efficiencies of corporate Centers of Excellence in pharmacovigilance. By highlighting these aspects, the whitepaper seeks to encourage a more holistic and forward-thinking approach to drug safety management.

    分享本文

    QbD Group

    Need expert guidance?

    准备加速您的生命科学项目?与我们的专家交流。

    获取专家指导 →

    继续阅读

    相关内容

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.